Aquestive Therapeutics Inc
Drug Manufacturers - Specialty & Generic
Healthcare
AQST
91.08 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
3.23
52 week high
5.66
high
3.30
52 week low
2.22
low
3.13
growth
-32.85 %
previous Close
3.21
P/E ratio
market cap
327 M
div yield
0
usd
Sep 2024
qoq
revenue
13.54 M
-32.62 %
net incoming
-11.51 M
-319.27 %
eps
0.00 %
-333.33 %
eps surprise
0.00 %
net profit margin
-84.99 %
-71.00 %
operating incoming
-8.29 M
-15.00 %
net change in cash
-11.98 M
-124.71 %
cash on hand
77.89 M
-13.33 %
cost of revenue
4.44 M
-1.97 %
top top